drugset / Trial / NCT00324922
Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary question of this study is to understand if trimethoprim-sulfamethoxazole (TMP-SMX) is as effective as vancomycin for treating methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis.
Timeline
- Start
- 2006-05-01
- Primary completion
- 2007-05-01
- Completion
- 2007-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sulfamethoxazole | Small molecule | 1600 mg | Oral |
| Comparator | Trimethoprim | Small molecule | 320 mg | Oral |
| Comparator | Vancomycin | Other / unclassified | 1 g | Intravenous |